Storebrand Asset Management’s Mural Oncology MURA Stock Holding History

Storebrand Asset Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-705	Closed	-$1.46K	–	806
2025 Q3	$1.46K	Hold	705	–	–	﹤0.01%	808
2025 Q2	$1.74K	Hold	705	–	–	﹤0.01%	809
2025 Q1	$888	Hold	705	–	–	﹤0.01%	824
2024 Q4	$2.27K	Hold	705	–	–	﹤0.01%	823
2024 Q3	$2.21K	Hold	705	–	–	﹤0.01%	860
2024 Q2	$2.21K	Hold	705	–	–	﹤0.01%	858
2024 Q1	$3.45K	Hold	705	–	–	﹤0.01%	859
2023 Q4	$4.17K	Buy	+705	New	+$2.83K	﹤0.01%	856

Storebrand Asset Management's MURA Position: Q4 2025 in Review

Storebrand Asset Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 705 shares — an estimated $1.46K sold.

Storebrand Asset Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $4.17K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Storebrand Asset Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Storebrand Asset Management sold 705 Mural Oncology shares in Q4 2025, an estimated $1.46K.
Storebrand Asset Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Storebrand Asset Management's Mural Oncology position peaked at $4.17K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Storebrand Asset Management's 13F filing for Q4 2025, filed 20 May 2026.